Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

thrombocytopenia/peavalu

Link salvestatakse lõikelauale
Leht 1 alates 822 tulemused

[Vascular headache, thrombopenia and serotonin metabolism].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The role of platelet serotonin in migraine remains a subject of controversy. However, the frequency of association of migraine with antibody-mediated thrombocytopenia would suggest that platelet dysfunction or impaired serotonin metabolism might play a role in migrainous attack. We report three new

Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Case 40-2017. A 32-Year-Old Woman with Headache, Abdominal Pain, Anemia, and Thrombocytopenia.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

[HEADACHES, weakness, and bleeding gums; thrombocytopenia].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

Cerebral Venous Thrombosis in a Patient with Iron Deficiency Anemia and Thrombocytopenia: A Case Report.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE To report a potential association of thrombosis, thrombocytopenia with iron deficiency anaemia. METHODS A 43-year-old female experienced an episode of a headache, with bilateral papilledema by neurological examination, magnetic resonance venography (MRV) brain showed cerebrovenous

Headache prevalence following recovery from TTP and aHUS.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Thrombotic thrombocytopenia purpura (TTP) and atypical hemolytic uremic syndromes (aHUS) are distinct clinical disorders characterized by hemolytic anemia, thrombocytopenia, microthrombi, and end organ damage. TTP is characterized by a low ADAMTS13 activity level at diagnosis of <10 % ADAMTS13
Thrombotic microangiopathy (TMA) is a recognized complication of malignant hypertension (HTN). Such patients have blood pressures > or = 200/140 mmHg but the condition is defined by the presence of papilledema and is frequently complicated by acute renal failure. Here we report two patients with

[Neutropenia and/or thrombocytopenia due to acute parvovirus B19 infection].

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Erythema infectiosum (fifth disease) is the most common clinical presentation of acute parvovirus B19 infection in infancy. In healthy adults, most cases of infection are asymptomatic or accompanied by a flu-like syndrome like headaches and myalgia. Haematological manifestations are dominated by

Acute disseminated encephalomyelitis and thrombocytopenia following Epstein-Barr virus infection.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Epstein-Barr Virus (EBV) causes a broad spectrum of disease in humans with several clinical syndromes and is ubiquitous, infecting more than 95% of the world's population. Central Nervous System (CNS) disease alone associated with Epstein-Barr virus rarely occurs in previously healthy individuals.

Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Fourteen patients with sexually transmitted human immunodeficiency virus (HIV)-related immune thrombocytopenia were treated with intravenous gammaglobulin (IVIG). The patients were treated with a uniform program consisting of 1 g/kg of IVIG on day 1 and day 2, followed by 1 g/kg on day 15. Most

Efficacy and safety of a new intravenous immunoglobulin (Panzyga® ) in chronic immune thrombocytopenia.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse

OBJECTIVES
To assess the efficacy and safety of intravenous immunoglobulin (IVIG) 10% (Panzyga® ), a novel human normal IVIG 10%, in patients with chronic immune thrombocytopenia (ITP).

First-line treatment options in ITP include

Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP).

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Eltrombopag is a thrombopoietin-receptor agonist that stimulates platelet production and increases platelet counts in patients with chronic immune thrombocytopenia (ITP). This open-label, single-arm study evaluated consistency of response and safety following repeated intermittent dosing of

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Eltrombopag is useful for immune thrombocytopenia (ITP). However, results of clinical trials may not accurately mirror clinical practice reality. Here we evaluated eltrombopag for primary and secondary ITP in our ≥65-yr-old population.106 primary ITP
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge